Bernard John Gersh
Mayo Clinic
2 papers in the Anchorcite directory, published between 2011 and 2019, cited 16,587 times in total.
ORCID profileResearch topics
- Acute Ischemic Stroke Management · 1 paper
- Atrial Fibrillation Management and Outcomes · 1 paper
- Venous Thromboembolism Diagnosis and Management · 1 paper
- Acute Myocardial Infarction Research · 1 paper
- Coronary Interventions and Diagnostics · 1 paper
- Cardiac Imaging and Diagnostics · 1 paper
Frequent co-authors
- Christopher Bull Granger · 1 paper
- John Hunter Alexander · 1 paper
- John J.V. McMurray · 1 paper
- Renato D. Lópes · 1 paper
- Elaine M. Hylek · 1 paper
- Hussein R. Al‐Khalidi · 1 paper
- Jack Ansell · 1 paper
- Dan Atar · 1 paper
Papers
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2011 · 9,052 citations
BACKGROUND: Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a…
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesEuropean Heart Journal · 2019 · 7,535 citations
Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or…
Metadata from OpenAlex (CC0).